Australian Commercial Services Stock News

Ramelius Resources (ASX:RMS) has just delivered its most profitable quarter on record, posting a 62% all in sustaining cost margin. Meanwhile, its share price has tracked lower alongside broader gold sector volatility. See our latest analysis for Ramelius Resources. Despite record profitability, Ramelius Resources’ recent momentum has cooled, with a 90 day share price return of a 27.97% decline and a year to date return of a 19.62% decline, even as the 3 year total shareholder return sits at...

Sonic Healthcare, one of the world's largest pathology providers, has recently reported that while revenue has grown over the past three years, profits have fallen sharply and the stock is now trading below its historical price-to-sales multiple. This combination of stronger top-line performance alongside weaker profitability raises important questions about how investors should interpret the company’s current valuation and operational trajectory. We’ll now examine how Sonic Healthcare’s...

Why Liontown's latest quarter matters for investors Liontown (ASX:LTR) just reported its strongest quarter since production began, with first time positive net cash flow linked to spodumene sales and an underground shift at Kathleen Valley, plus fresh expansion spending commitments. See our latest analysis for Liontown. The recent quarterly update and expansion plans appear to be feeding into strong momentum, with a 30 day share price return of 55.75% and a year to date share price return of...

Why PLS Group’s new debt deal matters for shareholders PLS Group (ASX:PLS) has closed a US$600 million 6.875% Senior Notes issue due 2031, refinancing its revolving credit facility and reshaping its debt profile to better match long term lithium operations. The company used part of the proceeds to repay the A$375 million drawn on its revolving credit facility, reducing the facility size from A$1,000 million to A$500 million. The remaining funds are earmarked for general corporate...

Those following along with Telix Pharmaceuticals Limited ( ASX:TLX ) will no doubt be intrigued by the recent purchase...

Why Boss Energy is back in focus after weather hit production Interest in Boss Energy (ASX:BOE) has picked up after the company reported a sharp fall in quarterly uranium production due to rain related disruptions, while keeping FY26 cost guidance and accelerating key expansion projects. See our latest analysis for Boss Energy. The weather hit production update landed against a weak backdrop for holders, with the share price logging a 26.9% decline over 90 days and a 60.2% fall in 1 year...

South32 (ASX:S32) has flagged about US$1.1b in additional capital expenditure for the Taylor project at its Hermosa asset, taking total projected spend to roughly US$3.3b. First production has been pushed back from mid 2027 to mid 2028, with full capacity now targeted for FY2031, one year later than previously indicated. The update includes a 52% uplift in Ore Reserves, an extended mine life to around 33 years, and extra decline infrastructure aimed at improving long term operating...

Capricorn Metals recently reported its March quarter, highlighting strong cash flows from the Karlawinda Gold Project and declaring its first fully franked interim dividend, while confirming the Karlawinda expansion remains on schedule for commissioning in early FY27. This combination of record cash generation, improved cost efficiency and a shift toward regular shareholder distributions marks an important maturation point in Capricorn Metals’ business profile. We’ll now examine how...

Elsight Limited recently held its Q1 2026 earnings call on 29 April 2026, following news that shareholder activist Stephen Mayne had nominated himself for election as a non-executive director under Rule 14.3 of the company’s constitution, a move the board has urged investors to vote against at the 29 May 2026 AGM. This combination of an upcoming contested board vote and fresh quarterly results puts Elsight’s governance approach and execution under closer investor scrutiny. We’ll now examine...

IperionX recently shifted its Virginia facility to 24/7 continuous titanium production, advancing a government-backed push to build a domestic titanium supply chain for U.S. defense and industrial uses. This operational step, combined with fresh insider share purchases and long-dated equity awards, highlights management’s strong alignment with the company’s long-term titanium and critical minerals ambitions. We’ll now explore how the move to continuous titanium production shapes IperionX’s...

Woolworths Group (ASX:WOW) has revised its earnings outlook following its Q3 trading update. Management cited material cost pressures, including inflation and fuel price impacts, as key factors influencing the new guidance. The company flagged increasing competitive and regulatory headwinds in Australia and New Zealand, particularly affecting its New Zealand operations. Woolworths also highlighted geopolitical risks as a source of ongoing uncertainty for future profitability. Woolworths...

Appen recently reported a quarterly update showing around 9% revenue growth, driven by strong performance in its China segment, while its core Appen Global division continued to suffer from steep revenue declines and EBITDA losses. Despite the contrasting fortunes of China and Appen Global, management kept full-year guidance unchanged, which appears to have frustrated investors looking for clearer evidence of a sustained turnaround in group profitability. We’ll now examine how the guidance...

In late April 2026, Mesoblast Limited reported it had completed patient recruitment for its pivotal 300-patient Phase 3 trial of rexlemestrocel-L in chronic low back pain due to degenerative disc disease, a placebo-controlled study designed around a 12-month pain reduction endpoint and supported by the therapy’s RMAT designation. This milestone moves rexlemestrocel-L closer to potential FDA submission for a condition affecting over 7 million Americans and heavily tied to opioid use,...

DroneShield (ASX:DRO) is back in focus after a sector wide lift in defence names, as governments increase spending on counter drone capabilities and the company heads into its Q1 2026 results and earnings call. See our latest analysis for DroneShield. DroneShield’s recent pullback, with a 30 day share price return of 9.3% and a 7 day decline of 3%, sits against a stronger 90 day share price return of 8.7% and a very large 1 year total shareholder return of 173.5%. This suggests longer term...

Codan recently issued a major earnings upgrade and FY26 trading update, indicating FY26 EBIT is expected to be more than 60% higher than FY25 and that its Communications segment has reached a 30% profit margin target earlier than previously guided. This simultaneous outperformance in both defence-focused communications and Minelab’s metal detection products suggests Codan’s diversified technology portfolio is currently converting sector demand into higher-than-expected profitability. We’ll...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

In April 2026, APA Group completed a A$1.50 billion debt raise, including A$1.00 billion in hybrid subordinated capital securities and A$500 million in 6.42% senior unsecured notes due 2036, to support its stated growth plans. The strong investor demand for these fixed-income securities, with the issuances reportedly nearly four times oversubscribed, underlines fixed-income appetite for APA’s income-focused infrastructure profile. Now we’ll consider how this heavily oversubscribed A$1.50...

Suncorp Group Limited recently completed a Fixed-Income Offering, issuing A$200 million of Floating Rate Hybrid Notes that are convertible, non-cumulative and subordinated, with a variable coupon structure. This hybrid issuance adds a new layer to Suncorp’s capital structure, blending debt and equity characteristics that may influence how investors assess its funding mix and risk profile. We’ll now examine how Suncorp’s use of subordinated, floating rate hybrid capital could reshape its...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

In late April 2026, Telix Pharmaceuticals reported Phase 2 OPTIMAL-PSMA dosimetry data for its second-generation prostate cancer candidate TLX597-Tx, showing low radiation uptake in non-target organs and supporting further evaluation in earlier-stage disease, while also progressing a Regeneron collaboration and a European review of its glioma imaging agent TLX101-Px. These developments highlight how Telix is trying to build an integrated radiopharmaceutical platform, pairing next-generation...

With the business potentially at an important milestone, we thought we'd take a closer look at 6K Additive, Inc.'s...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Cochlear Limited recently downgraded its FY26 net profit guidance from A$435–A$460 million to A$290–A$330 million, citing softer demand, delayed surgeries, and geopolitical disruptions in key markets. This setback has drawn attention to how dependent Cochlear’s earnings are on procedure volumes and hospital capacity, despite its strong competitive position in implantable hearing solutions. We’ll now examine how this earnings guidance cut, driven by weaker demand and delayed surgeries, may...

In late April 2026, Nickel Industries Limited reported its March quarter results, delivering record adjusted EBITDA of US$135.6 million, supported by a higher Indonesian production quota, accelerated ore sales, and progress on the Excelsior Nickel Cobalt project. Alongside this financial performance, the company highlighted a lost time injury frequency rate of 0.00, expanded conservation efforts over about 197 hectares of primary forest at Hengjaya, and a stronger liquidity position through...